SureTrader Advertisement PRTC
Home > Boards > Free Zone > Health and Sciences > Biotech Values

ARRY: New 8K irt Genentech agreement. Expansion to

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ThomasS Member Profile
 
Followed By 12
Posts 2,364
Boards Moderated 0
Alias Born 05/05/05
160x600 placeholder
S&P 500 Posts Biggest Weekly Gain In 2 Months
Equities brush aside Yellen hints at summer rate rise U.S. stocks closed higher Friday as investors brushed aside Federal Reserve...
Top Equities Stories Of The Day
Bank of America Relaunches Sale of Credit-Card Issuer MBNA
Culligan International Explores a Sale
Correction to Microsoft Smartphone Article on Wednesday
Facebook and Microsoft To Build Fiber Optic Cable Across Atlantic
Silicon Valley Driverless-Car Startup Raises Fresh Capital
ADRs End Mostly Lower; Alibaba, Baidu Trade Actively
Correction to Valeant CEO Article on April 21
Thermo Fisher Scientific to Buy FEI for $4.2 Billion
ThomasS   Monday, 09/08/08 07:36:58 AM
Re: None
Post # of 201649 
ARRY: New 8K irt Genentech agreement. Expansion to include a new target under the existing collaboration #msg-29627295:

Array BioPharma Inc. (the "Company") and Genentech, Inc. ("Genentech") have entered into an amendment effective as of September 1, 2008 (the "Amendment") to the Drug Discovery Collaboration Agreement between the Company and Genentech dated December 22, 2003, as amended (the "Agreement"). Under the Amendment, the Company and Genentech added a new collaboration target and agreed to increase the number of the Company's full-time equivalent scientists ("FTEs") performing services under the Agreement. Genentech continues to have the right to reduce the number of FTEs under the Agreement after January 1, 2010, subject to higher minimum levels set forth in the Amendment. The Amendment also provides for the payment of a one-time license fee, research funding and milestone payments to the Company in connection with the new target.

"Illegitimacy is something we should talk about in terms of not having it."

- Dan Quayle
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist